Trupanion, Inc.

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: US8982021060
USD
37.03
2.19 (6.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Trupanion, Inc. stock-summary
stock-summary
Trupanion, Inc.
Insurance
Trupanion, Inc. provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers. The other business segment includes other operations that are not directly marketed to consumers. The Company offers a software solution, Trupanion Express, which is designed to facilitate the direct payment of invoices to veterinary practices. Trupanion Express integrates with veterinarians' practice management software, which allows the Company to access data. The Company's subsidiaries include American Pet Insurance Company, Trupanion Managers USA, Inc., Trupanion Brokers Ontario, Inc. and Wyndham Insurance Company (SAC), Ltd.
Company Coordinates stock-summary
Company Details
6100 4th Ave S Ste 200 , SEATTLE WA : 98108-3234
stock-summary
Tel: 1 888 73874781 206 6071929
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 55 Schemes (38.48%)

Foreign Institutions

Held by 120 Foreign Institutions (21.97%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Murray Low
Independent Chairman of the Board
Mr. Darryl Rawlings
President, Chief Executive Officer, Director
Mr. Eric Johnson
Director
Ms. Jacqueline Davidson
Independent Director
Mr. Michael Doak
Independent Director
Ms. Robin Ferracone
Independent Director
Mr. Dan Levitan
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
9 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 1,906 Million (Small Cap)

stock-summary
P/E

2,162.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

4.56%

stock-summary
Price to Book

5.36